TSHA
Taysha Gene Therapies, Inc. Common Stock ·
Taysha Gene Therapies, Inc. Common Stock (TSHA) is held by 1 tracked hedge fund(s). Largest tracked holder: RTW INVESTMENTS, LP.
Insider trades open-market, past year
No reported open-market insider trades in the past year.
Open-market Form 4 transactions (grants & option exercises excluded). Live from SEC filings.
Congress buys & sells disclosed trades
No disclosed Congressional trades on this stock.
Price chart
Financials
Symbol info, price chart & financials are live from TradingView (real data — no processing).
📊
Deep Dive — full fundamental analysis
An analyst-grade breakdown of TSHA: the bull & bear thesis, valuation model, segment detail and risks — written from SEC filings.
- Bull & bear case, with conviction score
- Owner-earnings & valuation model
- Segment & geographic revenue breakdown
- Key risks & what would break the thesis
- Peer comparison (vs sector)
🔒 Unlock with WealthFile Pro
⚡
Daily Moves — what's moving TSHA today
A daily, plain-English read on the day's price action and the smart-money & news catalysts behind it.
- Today's price drivers, explained
- Smart-money flow alerts (fund / insider / Congress)
- News & SEC-filing catalysts
- Unusual options activity
🔒 Unlock with WealthFile Pro
Related ▾
FAQ ▾
Which hedge funds hold TSHA?
Tracked holders include: RTW INVESTMENTS, LP.
How much smart money owns TSHA?
1 tracked hedge fund(s) have disclosed positions.
Are members of Congress trading TSHA?
No tracked Congressional trades in TSHA on file.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings · Not investment advice ▾
Ownership from SEC filings; price from market data.
Published by WealthFile · Not investment advice.